Ginhawa (ReliefVent) 




The people’s “breath of relief” ventilator

The Problem:

50% of ICU patients need a ventilator. In many developing countries like the Philippines, there is only 1 ventilator per 10 ICU beds which may result to unwanted increase in mortality rates. The prohibitive cost of acquiring a ventilator plus the inaccessibility of spare parts when a ventilator breaks down poses a challenge for small hospitals to acquire more units.

The Solution:

Developed by a team of critical care specialists, biomedical engineers, software specialist and biomed technicians, Ginhawa (ReliefVent) is a ventilator that can be used for both children and adults. It is projected to cost 40% lower than other portable ventilators in the market.

Target Market:

Hospitals, clinics, ambulance services

Features:

It is compact, portable, and can be AC or DC powered. It has embedded software for self-diagnostic cloud-based data analytic, with protocols for operations and trouble-shooting.

Status and Needs:

The product is relatively lightweight (8kg) unit and mainly powered by compressed air. It can do controlled ventilation, assist-control ventilation, and synchronous intermittent mandatory ventilation. It contains an internal differential pressure transducer for detecting patient inspiratory efforts and refinement of the internal oxygen blender and humidifier, which is uncommon to most of the commercially-available ventilators. Benchtesting using Michigan Instruments Pneuview Test Lung and animal (dog) studies testing were done, proving its safety and efficacy. It is currently undergoing human trials.

The proponent is currently seeking a manufacturing company that will add to its value engineering both for the software and hardware, and a partner for its commercialization.

Contact Person:

Abundio Balgos, MD, MHA, FPCP, FPCCP
Professor, UP College of Medicine
University of the Philippines Manila
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

THE LEADERS IN INNOVATION FELLOWSHIP PROGRAM

Filipino researchers who qualify for the LIF program will spend a focused period of training and coaching in the United Kingdom. They will attend master classes given by Fellows of the Royal Academy of Engineering and enjoy opportunities for international networking.

The minimum requirement for researchers to qualify for LIF 5: Their technology should have received prior funding from the Philippine Department of Science and Technology.

A postgraduate certificate program established in 2014, LIF creates international networks of innovators, expert mentors, and technology entrepreneurs. On their return to the Philippines, LIF Fellows continue to benefit from ongoing training and support to push their commercialization plan forward.

Leaders in Innovation Fellowship is part of the Newton Agham Programme, a collaboration between the UK and Philippine governments to bolster science, research, and innovation. The LIF program is delivered by the Royal Academy of Engineering in partnership with the Philippine Department of Science and Technology and the Asian Institute of Management.

WHAT IS NEWTON AGHAM?

The Newton Agham (Science) Programme is a collaboration between the UK and the Philippines to advance science, research, and innovation. The UK Government, through its embassy in the Philippines, works with UK delivery partners and Philippine science and innovation institutions to implement programs that strengthen science and innovation capacity.

Partner institutions include the Department of Science and Technology and the Commission on Higher Education. UK delivery partners working in the Philippines include the British Council, Medical Research Council, Biotechnology and Biological Sciences Research Council, Research Councils UK, and the Royal Academy of Engineering.

Globally, the UK government launched the Newton Fund in 2014, a £735-million fund to support science and innovation partnerships with emerging knowledge economies. The Fund is part of the UK’s Official Development Assistance and covers three broad categories of activity.

  • People – Increasing capacity in science and innovation, individually and institutionally, in partner countries
  • Programs – Research collaborations on development topics
  • Translation – Creating collaborative solutions to development challenges and strengthening innovation systems

HOW IT WORKS

LIF is a multi-phase program delivered over 12 months. It is a multi-sectoral partnership among top institutions in the UK and the Philippines in the fields of science, innovation, and leadership management.

The Fellowship is open to all academic researchers across the country and Technology Transfer Officers with DOST-funded technology, who are in the process of developing a business plan for their technology or innovation. While the most ideal candidates are those who have tested their idea in the market, candidates who are on the cusp of commercialization may also be considered.

The Philippine Department of Science and Technology (DOST) will accept applications from scientists, academic researchers, and technology innovators across the country. A DOST planning council, the Philippine Council for Agriculture, Aquatic, and Natural Resources Research and Development, will be the primary implementing and monitoring arm for the duration of the program.

HOW TO APPLY

Fill out the Online Application Form.

F
OR MORE INFORMATION

This email address is being protected from spambots. You need JavaScript enabled to view it.
aim.edu/lif

 
 

 



September 26, 2018 - Swinburne University of Technology (SUT) of Melbourne, Australia signed a memorandum of understanding (MOU) with the Department of Science and Technology - Philippine Council for Health Research and Development (DOST-PCHRD) for scientific and technological collaboration specifically in the fields of biomedical devices and digital health. Representing the Philippines in the signing ceremony was PCHRD Executive Director, Dr. Jaime Montoya, while representing the SUT was Dr. Janet Hiller, Dean of Health Sciences.

The MoU aims to develop cooperation and collaboration between the two institutions to accelerate development in S&T through collaborative activities and contribute to the attainment of the national health goals.

Under the MOU, SUT and DOST-PCHRD will work together on joint researches, capacity building such as research training, scholarships, exchange programs, and curricular development, and knowledge and expertise sharing.

Dr. Janet Hiller, addressing on this occasion, stressed that the collaboration reflects a strong commitment of using the power of data science and digital technology to improve the health of the communities. Given the challenge in size and demographics of Australia and the Philippines, the collaboration hopes to find solutions aiming to providing equitable, safe, and effective health services across very dispersed populations.

Likewise, DOST-PCHRD Executive Director, Dr. Montoya assured SUT representatives of the Council’s full support in this collaboration.

The SUT delegation also visited higher education institutes, University of Santo Tomas, University of the Philippines, and De La Salle University to discuss their initiatives on data science and biomedical devices innovation offered by their institution and met with the Department of Health for possible collaboration on health technology assessment.

The Philippine Health Insurance Corporation and the Philippine Council for Health Research and Development are inviting researchers to submit capsule proposals for the study entitled: “Informal Economy Segmentation Study: Towards Universal Healthcare in the Philippines – Reaching and Retaining Members in the Informal Sector”

The project Terms of References can be downloaded here. 

The 2017 PhilHealth STUDIES (Strengthening the Thrust for Universal Health Care through Data, Information, and Knowledge Exchange Systems) is a research management collaboration between the Philippine Health Insurance Corporation (PhilHealth) and the Philippine Council for Health Research and Development (PCHRD). This initiative aims to provide funding for research projects focusing on the development of evidence-based policy recommendations on PhilHealth programs and services.

Who may apply
Filipinos with at least a Master’s Degree in a relevant field, have proven research competence/track record, and employed in universities/colleges, research agencies/institutes, hospitals, and other health related agencies are eligible to apply for the research grant.

Requirements
We encourage interested parties to submit their capsule proposals via email to This email address is being protected from spambots. You need JavaScript enabled to view it. and attach the following documents by October 9, 2018:

1. Letter of Intent addressed to:

The Executive Director

Philippine Council for Health Research and Development
Department of Science and Technology, Saliksik Bldg.
Gen. Santos Avenue
Bicutan, Taguig City, Metro Manila

2. Curriculum Vitae of Lead Researcher


3. Profile of Institution


4. Capsule Proposal Format 


If you have queries, please contact Mr. Marc Enrico Hasta (This email address is being protected from spambots. You need JavaScript enabled to view it.) or Ms. Grace Ann Cenon (This email address is being protected from spambots. You need JavaScript enabled to view it.) or call (02)837-75-34 to 37 loc. 206.



Every year, the Department of Science and Technology (DOST) goes around the different regions to showcase notable outputs from research and development.  In the recently concluded Caraga Regional Science and Technology Week in Butuan on 5-8 September, 2018, DOST Secretary Fortunato de la Peña presented 15 breakthrough technologies from the different DOST agencies.  

 Three out of the 15 R&D programs and projects cited by the Secretary were supported and/or implemented by the of the Philippine Council for Health Research and Development are as follows:

  1. Standardized and Clinically-tested Herbal Medicine
  • Tuklas Lunas Program

One of the health research and development priorities under the Harmonized National Research and Development Agenda (HNRDA) and the National Unified Health Research Agenda (NUHRA) 2017-2022, Tuklas Lunas or the Philippine Drug Discovery and Development Program aims to develop standardized herbal drugs from the country’s marine and terrestrial resources.Successful outputs of the program include the  commercialization of lagundi tablets for cough and sambong as anti-urolithasis or for treating kidney stones. The program also aims to establish Tuklas Lunas Development Centers (TLDCs), which will serve as screening and extraction centers in Higher Education Institutes (HEIs).  

  • Leptovax

An animal vaccine developed by the University of the Philippines Manila to protect housepets and livestock from the Leptospira bacteria transmitted by rats. LeptoVax aims to address and mitigate outbreaks of leptospirosis in the country. While trials are still not fully complete, the developers are looking forward to test the vaccine to larger animals like carabaos and dogs, and also be able to eventually produce a vaccine that can be used in humans.

  1. Medical Implants

A total knee replacement system developed for Asian and Filipino  body structure, the axis knee system provides a more affordable knee replacement system which uses a novel instrument to ensure correct knee alignment. Manufactured locally by Orthopaedic International Inc., the patented instrument and surgical technique allows general orthopedic surgeons to perform the procedure accurately even without the use of x-rays. 

  1. Diagnostic Kits

Developed by the Institute of Molecular Biology and Biotechnology, National Institutes of Health, University of the Philippines Manila, the Biotek-M Dengue Aqua Kit is a confirmatory test for dengue that allows faster results while remaining affordable compared to other Polymerase Chain Reaction (PCR) tests. The development of Biotek-M also resulted in the University of the Philippines’ first spin-off company, Manila HealthTek Inc., which now manufactures and distributes the devices commercially.

 

Aside from three PCHRD-initiated and supported breakthroughs, the Secretary also presented biofertilizers and plant growth enhancers, protein rich copra meal, agriculture and aquaculture productivity technologies, native livestock purelines technology, educational tools, supplementary foods and ready-to-eat foods for disaster victims, water treatment materials, among others.

In closing, the Secretary highlighted the significance of technology transfer and adoption of these technologies in the country. He encouraged different sectors in the region to work together in the spirit of cooperation for collective prosperity.

 The Caraga Regional Science and Technology Week is part of the National Science Technology Week Celebrations which aims to bring the Department’s technologies, programs, and services to the regions. The event also featured project visits including the Eel Farm in Cabadbaran City, Agusan del Norte, Hillsview and VPO Enterprises in Trento and Rosario, Agusal del Sur.

For more information on other upcoming RSTW celebrations, please visit http://nstw.dost.gov.ph/